Coronavirus disease 2019 (COVID-19) is an ongoing pandemic that has spread to almost all countries worldwide Diabetes mellitus (DM) has been shown to increase the risk of COVID-19 disease severity In this review, we provide a summary of the impact of COIVD-19 on diabetes management and related services We searched the literature using the following databases: PubMed, Medline, Scopus and Google Scholar These databases were searched using the keywords: COV-ID-19, diabetes type 1 and type 2 Lockdown causing social isolation and psychological issues, showed an influence on poor glycemic control amongst people with diabetes Hence, the use of telemedicine and various technologies in the management of diabetes has substantially increased In individuals with COVID-19, the current practice is not in favor of using sodium-glucose cotransporter 2 (SGLT2) inhibitors Furthermore, insulin is recommended for the management of diabetes in critically ill patients The COVID-19 pandemic was associated with many changes in diabetes management and the delivery of diabetes services © The authors
What are the changes and burden associated with covid-19 in diabetes management and delivery of the diabetes services?